XFRA CAPITAL ADJUSTMENT INFORMATION

XFRA CAPITAL ADJUSTMENT INFORMATION - 03.10.2024

Das Instrument 5MP US59564R7089 BIODEXA PHARMA S. LS-,02 EQUITY wird cum Kapitalmassnahme gehandelt am 03.10.2024 und ex Kapitalmassnahme am 04.10.2024
The instrument 5MP US59564R7089 BIODEXA PHARMA S. LS-,02 EQUITY is traded cum capital adjustment on 03.10.2024 and ex capital adjustment on 04.10.2024

Das Instrument 69P FR0010380626 PROLOGUE S.A.INH.B EO-,01 EQUITY wird ex Kapitalmassnahme gehandelt am 03.10.2024
The instrument 69P FR0010380626 PROLOGUE S.A.INH.B EO-,01 EQUITY is traded ex capital adjustment on 03.10.2024

Das Instrument 7HW SE0015812516 WYLD NETWORKS AB EQUITY wird cum Kapitalmassnahme gehandelt am 03.10.2024 und ex Kapitalmassnahme am 04.10.2024
The instrument 7HW SE0015812516 WYLD NETWORKS AB EQUITY is traded cum capital adjustment on 03.10.2024 and ex capital adjustment on 04.10.2024

Das Instrument 6W8 US2920343033 EMPIRE PETROLEUM DL-,001 EQUITY wird ex Kapitalmassnahme gehandelt am 03.10.2024
The instrument 6W8 US2920343033 EMPIRE PETROLEUM DL-,001 EQUITY is traded ex capital adjustment on 03.10.2024

6 Richtige für 2025

Das Börsenjahr 2025 klopft schon an die Tür – und wie immer geht es um die Frage: Welche Aktien werden die großen Gewinner sein? Die Auswahl an Möglichkeiten ist riesig, doch nur ein paar echte Volltreffer stechen heraus.

Ob stabiler Dividenden-Lieferant, Tech-Pionier oder spekulative Wette im Krypto-Bereich – wir haben die Märkte für Sie ausgiebig durchforstet und präsentieren Ihnen 6 Unternehmen, die große Chancen auf außergewöhnliche Kurssteigerungen besitzen. Hier sind, speziell für Sie, Ihre „6 Richtigen“ für 2025.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche Unternehmen das Potenzial besitzen, im kommenden Jahr richtig durchzustarten!

Hier klicken

Zeit	Aktuelle Nachrichten
04.12.	Biodexa Pharmaceuticals Plc - 6-K, Report of foreign issuer
22.11.	Biodexa Pharmaceuticals PLC: Result of General Meeting	November 22, 2024 Biodexa Pharmaceuticals PLC ("Biodexa" or the "Company") Result of General Meeting Biodexa Pharmaceuticals PLC ("Biodexa" or the "Company") (NASDAQ: BDRX), a clinical stage biopharmaceutical... ► Artikel lesen
21.11.	Biodexa Pharmaceuticals PLC: Gaining Momentum, Biodexa is Advancing Two Recent Acquisitions Through the Clinic	CARDIFF, UK / ACCESSWIRE / November 21, 2024 / Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), an acquisition-focused clinical-stage biopharmaceutical company focused on developing treatments for unmet medical... ► Artikel lesen
12.11.	Biodexa Pharmaceuticals erfüllt wieder Nasdaq-Anforderungen
12.11.	Biodexa Pharmaceuticals regains Nasdaq compliance

Zeit

Aktuelle Nachrichten

04.12.

Biodexa Pharmaceuticals Plc - 6-K, Report of foreign issuer

22.11.

Biodexa Pharmaceuticals PLC: Result of General Meeting

November 22, 2024 Biodexa Pharmaceuticals PLC ("Biodexa" or the "Company") Result of General Meeting Biodexa Pharmaceuticals PLC ("Biodexa" or the "Company") (NASDAQ: BDRX), a clinical stage biopharmaceutical...
► Artikel lesen

21.11.

Biodexa Pharmaceuticals PLC: Gaining Momentum, Biodexa is Advancing Two Recent Acquisitions Through the Clinic

CARDIFF, UK / ACCESSWIRE / November 21, 2024 / Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), an acquisition-focused clinical-stage biopharmaceutical company focused on developing treatments for unmet medical...
► Artikel lesen

12.11.

Biodexa Pharmaceuticals erfüllt wieder Nasdaq-Anforderungen

12.11.

Biodexa Pharmaceuticals regains Nasdaq compliance

Zeit	Aktuelle Nachrichten
22.11.	EMPIRE PETROLEUM CORP - 8-K, Current Report
22.11.	Empire Petroleum amends loan agreement with Equity Bank
15.11.	EMPIRE PETROLEUM CORP - 8-K, Current Report
14.11.	Empire Petroleum Non-GAAP EPS of -$0.12, revenue of $10.89M
14.11.	Empire Petroleum Posts Wider Loss In Q3

Zeit

Aktuelle Nachrichten

22.11.

EMPIRE PETROLEUM CORP - 8-K, Current Report

22.11.

Empire Petroleum amends loan agreement with Equity Bank

15.11.

EMPIRE PETROLEUM CORP - 8-K, Current Report

14.11.

Empire Petroleum Non-GAAP EPS of -$0.12, revenue of $10.89M

14.11.

Empire Petroleum Posts Wider Loss In Q3

Zeit	Aktuelle Nachrichten
03.10.	XFRA CAPITAL ADJUSTMENT INFORMATION - 03.10.2024		Das Instrument 5MP US59564R7089 BIODEXA PHARMA S. LS-,02 EQUITY wird cum Kapitalmassnahme gehandelt am 03.10.2024 und ex Kapitalmassnahme am 04.10.2024 The instrument 5MP US59564R7089 BIODEXA PHARMA... ► Artikel lesen

Zeit

Aktuelle Nachrichten

03.10.

XFRA CAPITAL ADJUSTMENT INFORMATION - 03.10.2024

Zeit	Aktuelle Nachrichten
03.12.	Correction: Warrants of series TO5 were subscribed to approximately 87.1 percent and Wyld Networks AB receives approximately SEK 234 thousand
29.11.	Warrants of series TO5 were subscribed to approximately 69.5 percent and Wyld Networks AB receives approximately SEK 0.2 million
29.11.	Wyld Networks AB: Wyld Networks' Interim Report Q3 2024	STRENGTHENING WYLD'S FUTURE BY RESETTING STRATEGY AND ORGANISATION WITH FOCUS ON DELIVERY AND GROWTH The Company have undertaken an organisational restructure, a new strategy and a cost cutting exercise... ► Artikel lesen
26.11.	WYLD NETWORKS: STRENGTHENING WYLD'S FUTURE WITH NEW STRATEGY, STREAMLINING COSTS AND NEW ORGANISATION STRUCTURE WITH FOCUS ON DELIVERY AND GROWTH
25.11.	The last day of trading with the warrants of series TO5 in Wyld Networks AB is today, November 25, 2024

Zeit

Aktuelle Nachrichten

03.12.

Correction: Warrants of series TO5 were subscribed to approximately 87.1 percent and Wyld Networks AB receives approximately SEK 234 thousand

29.11.

Warrants of series TO5 were subscribed to approximately 69.5 percent and Wyld Networks AB receives approximately SEK 0.2 million

29.11.

Wyld Networks AB: Wyld Networks' Interim Report Q3 2024

STRENGTHENING WYLD'S FUTURE BY RESETTING STRATEGY AND ORGANISATION WITH FOCUS ON DELIVERY AND GROWTH The Company have undertaken an organisational restructure, a new strategy and a cost cutting exercise...
► Artikel lesen

26.11.

WYLD NETWORKS: STRENGTHENING WYLD'S FUTURE WITH NEW STRATEGY, STREAMLINING COSTS AND NEW ORGANISATION STRUCTURE WITH FOCUS ON DELIVERY AND GROWTH

25.11.

The last day of trading with the warrants of series TO5 in Wyld Networks AB is today, November 25, 2024

Unternehmen / Aktien	Kurs	%
BIODEXA PHARMACEUTICALS PLC ADR	3,900	-0,51 %
EMPIRE PETROLEUM CORPORATION	5,150	+5,10 %
PROLOGUE SA	0,178	+1,14 %
WYLD NETWORKS AB	0,002	0,00 %

Unternehmen / Aktien

Kurs

BIODEXA PHARMACEUTICALS PLC ADR

3,900

-0,51 %

EMPIRE PETROLEUM CORPORATION

5,150

+5,10 %

PROLOGUE SA

0,178

+1,14 %

WYLD NETWORKS AB

0,002

0,00 %

	Indizes	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage


	Aktien	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage


	Xetra-Orderbuch


	Fonds	Kurs	%


	Devisen	Kurs	%


	Rohstoffe	Kurs	%


	Themen	Kurs	%



Erweiterte Suche